Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03050242Completed
Randomised, open-label trial of glycopyrronium (2 arms). Primary endpoint: Degree of Secretion. Started Mar 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03050242.